Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity

NCT00277641 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Binge Eating Disorder
Obesity

Interventions

DRUG: Lamotrigine
DRUG: placebo

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]
[object Object]